JosephDiNorciaIIIMD

Hepatobiliary Surgery, Pancreas, Transplantation

Associate Professor of Surgery - Surgical Director, Pediatric Liver Transplant Recanati/Miller Transplantation Institute - Mt. Sinai Hospital

Dr. DiNorcia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
5 E 98th St
Fl 12
New York, NY 10029
Phone+1 212-241-8035

Fax+1 212-241-2064

Dr. Joseph DiNorcia is a general surgeon in New York, NY and is affiliated with The Mount Sinai Hospital. He received his medical degree from Georgetown University School of Medicine and has been in practice 12 years. He specializes in hepatobiliary surgery, pancreas, and transplantation and is experienced in biliary atresia, hepatocellular carcinoma, cholangiocarcinoma, hepatoblastoma, and transplant surgery. He has more than 40 publications and over 500 citings.

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Abdominal Transplant Surgery, 2012 - 2014
New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 2005 - 2012
Georgetown University School of MedicineClass of 2005
Georgetown UniversityMS, Physiology and Biophysics, magna cum laude, 2000 - 2001
Princeton UniversityBA, English, 1996 - 2000

PubMed

56 citations
Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection.
Irene Epelboym, Megan Winner, Joseph DiNorcia, Minna K. Lee, James A. Lee
The Journal of Surgical Research. 2014-03-01
82 citations
Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients.
Takahiro Ito, Bita V. Naini, Daniela Markovic, Antony Aziz, Stephanie Younan
American Journal of Transplantation. 2021-02-01
80 citations
TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-initiating Stem-like Cells in Livers of Mice
Dinesh Babu Uthaya Kumar, Chia-Lin Chen, Jian-Chang Liu, Douglas E. Feldman, Linda Sher
Gastroenterology. 2016-03-01

Journal Articles

Coil-Assisted Retrograde Transvenous Obliteration (CARTO): An Alternative Treatment Option for Refractory Hepatic Encephalopathy
Fady Kaldas, Francisco Durazo, Siddharth A Padia, Justin P McWilliams, Joseph 3rd DiNorcia, Edward Wolfgang Lee, Ronald W Busuttil, Nature

How to Know if Your Child Has Rare Hepatitis That's Affecting Hundreds of Children GloballyMay 17th, 2022
What to Know About the Mysterious Rise in Pediatric Hepatitis Cases, According to a DoctorMay 13th, 2022